ACTIP objectives and scope

ACTIP is an independent and informal, science-based forum of European companies with an active interest in the use of animal cell technology in the development and production of biopharmaceuticals, vaccines and other preventative or therapeutic approaches.

Its objectives are:

• Intensive networking among the member companies, with SMEs and academics working in the field to increase European competitiveness.
• Directing the attention on initiation, generation and accomplishment of work and research projects sponsored by the European Commission.
• Join industry and academics for focusing on technological and applied-oriented challenges.
• Following new aspects in research, development and technology.
• Speaking up for an increased recognition of young scientists in the field of animal cell technology. Introducing young scientists working in the field of animal cell technology to the ACTIP network by the ACTIP Fellowship Award.

For purposes of definition, mammalian cell technology is considered to include animal cells, human cells, primary cells, insect cells and stem cells.
New developments in other cell types are reported on regularly.

ACTIP’s focus is primarily industrial, although very good relations are maintained with academics and non-member SMEs working in the field (see also ’interesting links´).

Revised June 9, 2011